Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2499 (LINC02499)

Target
LINC02499
Molecular classification
Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 2499 (LINC02499) is a human long intergenic non-coding RNA (lincRNA) gene located at chromosome 4q13.3. LINC02499 does not code for a protein and belongs to the class of long non-coding RNAs, which are typically >200 nucleotides and act primarily through regulation of gene expression. Biologically, LINC02499 functions as a molecular sponge for the microRNA miR-329-5p, modulating the expression of CYP3A5, a key drug-metabolizing enzyme in liver cells. LINC02499 is expressed in the liver and has been implicated in the suppression of hepatocellular carcinoma progression, making it of interest as a putative biomarker for diagnosis and prognosis in liver cancer. There are no approved drugs reported to directly target or interact with LINC02499, and its role is better described as a regulator of gene expression than as a traditional therapeutic target like receptors or enzymes.

Other names
hCG1813624LINC02499
02

Mechanism of action

Molecular sponge for miR-329-5p, mitigating its inhibition of CYP3A5 mRNA

03

Biological functions

Regulation of gene expression (specifically, it acts as a molecular sponge for microRNA)Regulation of drug-metabolizing enzyme (specifically CYP3A5 expression in hepatocytes)
04

Disease associations

Cancer (notably, hepatocellular carcinoma)
05

Biomarkers

Potential diagnostic and prognostic biomarker in liver disease and hepatocellular carcinoma

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2499 (LINC02499).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2499 (LINC02499).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call